SCHEMBL8796548

SCHEMBL8796548

CCCCCOc1ccc(/C=C(\CO[Si](C)(C)C(C)(C)C)c2cccc(C(=O)OC)c2)cc1OCCCCC

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 4/20 0.37
CNR2 P34972 3/20 0.37
HPGD P15428 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
HSP90AA1 P07900 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MDH1 P40925 2/20 0.36
PTPN11 Q06124 1/20 0.36
PLA2G4A P47712 2/20 0.35
LTB4R Q15722 1/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8796557 1.00 SMPD1 (0.37) SMPD1CNR2HPGDALDH1A1CYP1A2
SCHEMBL8795820 0.91 NPC1 (0.39) HPGDCYP1A2MAPTCYP2C9CYP2C19
SCHEMBL8795809 0.91 NPC1 (0.39) HPGDCYP1A2MAPTCYP2C9CYP2C19
SCHEMBL8797129 0.88 PLA2G4A (0.48) SMPD1MAPTSMN1; SMN2MDH1PLA2G4A
SCHEMBL8797137 0.88 PLA2G4A (0.48) SMPD1MAPTSMN1; SMN2MDH1PLA2G4A
SCHEMBL8796289 0.87 PTPN11 (0.36) SMPD1HPGDALDH1A1SMN1; SMN2PTPN11
SCHEMBL8796294 0.87 PTPN11 (0.36) SMPD1HPGDALDH1A1SMN1; SMN2PTPN11
SCHEMBL8796569 0.86 PTPN11 (0.37) SMPD1HPGDSMN1; SMN2PTPN11PLA2G4A
SCHEMBL8796565 0.86 PTPN11 (0.37) SMPD1HPGDSMN1; SMN2PTPN11PLA2G4A
SCHEMBL8795594 0.84 SMPD1 (0.42) SMPD1CNR2HPGDALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0629604-B1 Alicyclic phospholipase A2 inhibitors BRISTOL MYERS SQUIBB CO (US) 1997-04-16 EP disclosed
US-5436369-A Alicyclic phospholipase A2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1995-07-25 US disclosed